ConductScience.org, home

Paper30809482

Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.

Guclu H and 1 other. Int J Ophthalmol, 2019. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome. Papers, record 30809482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30809482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.
PubMed
Journal
Int J Ophthalmol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.34
iCite
Revised in PubMed
2020-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guclu HHande
2Pelitli Gurlu VVuslat

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110360304The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.Trans Am Ophthalmol Soc1998https://conductscience.org/library/papers/10360304PubMed
210850857Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.Inflammation2000https://conductscience.org/library/papers/10850857PubMed
310850858Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.Inflammation2000https://conductscience.org/library/papers/10850858PubMed
412189605Topical nonsteroidal antiinflammatory drugs in ophthalmology.Int Ophthalmol Clin2002https://conductscience.org/library/papers/12189605PubMed
512551663Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.J Cataract Refract Surg2003https://conductscience.org/library/papers/12551663PubMed
714635785Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac.Inflammation2003https://conductscience.org/library/papers/14635785PubMed
815035387Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. 1966.Retina2003https://conductscience.org/library/papers/15035387PubMed
91549810Cyclo-oxygenase inhibitors in ophthalmology.Surv Ophthalmol1992https://conductscience.org/library/papers/1549810PubMed
1016077349Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.Retina2005https://conductscience.org/library/papers/16077349PubMed
1116234444Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review.Br J Ophthalmol2005https://conductscience.org/library/papers/16234444PubMed
1216931266Cystoid macular edema after pars plana vitrectomy for retained lens fragments.J Cataract Refract Surg2006https://conductscience.org/library/papers/16931266PubMed
1317016463Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.Eye (Lond)2008https://conductscience.org/library/papers/17016463PubMed
1417189793Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.J Cataract Refract Surg2007https://conductscience.org/library/papers/17189793PubMed
1517397743Successful treatment of cystoid macular edema with valdecoxib.J Cataract Refract Surg2007https://conductscience.org/library/papers/17397743PubMed
1617558326Evaluation of costs for cystoid macular edema among patients after cataract surgery.Retina2007https://conductscience.org/library/papers/17558326PubMed
1717720069Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment.J Cataract Refract Surg2007https://conductscience.org/library/papers/17720069PubMed
1818165084Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.J Cataract Refract Surg2008https://conductscience.org/library/papers/18165084PubMed
1918599019A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.Am J Ophthalmol2008https://conductscience.org/library/papers/18599019PubMed
2018599569Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.Invest Ophthalmol Vis Sci2008https://conductscience.org/library/papers/18599569PubMed
2118854783Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema.Retina2009https://conductscience.org/library/papers/18854783PubMed

See all 64 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42271301Comparison of topical nepafenac 0.1% and 0.3% for the treatment of pseudophakic cystoid macular edema following cataract surgery.BMC Ophthalmol2026https://conductscience.org/library/papers/42271301PubMed
34740334Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema.BMC Ophthalmol2021https://conductscience.org/library/papers/34740334PubMed
34640393Current Management Options in Irvine-Gass Syndrome: A Systemized Review.J Clin Med2021https://conductscience.org/library/papers/34640393PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30809482

GET https://conductscience.org/api/papers/v1/30809482/references?page=2